Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2020-03-09
2020-09-08
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Examining the Effects of Float-REST for Recovery in Individuals With Chronic Lower Back Pain
NCT05260918
This Project is a Three-arm RCT Evaluating Two, Single-session Behavioral Interventions for Adults With Chronic Musculoskeletal Pain (CMP) -- 1) Brief Mindfulness-Oriented Recovery Enhancement (B-MORE) vs. Empowered Relief (ER) -- Relative to the Traditional 8-week Version of MORE.
NCT07193095
Myofascial Trigger Point Release and Paced Breathing Training for Chronic Low Back Pain
NCT04107597
Development and Feasibility of Mindfulness Based Pain Reduction
NCT04980612
The Effect of ESWT Added to Conservative Treatment on Pain, Disability, and Ultrasonographic Outcomes in Chronic Low Back Pain
NCT07132762
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Floatation-REST
Participants will float in a shallow pool of water with about 1000 pounds of epsom salt, in a light and sound attenuated device, for up to 60 minutes. Following the session, participants' ratings of the experience will be measured.
Flotation-REST
Floating in a specialized device (float pod or float cabin) used to attenuate sensory input.
Dark Room
Participants will lay on an air mattress in a dark and quiet room, with reduced environmental stimulation, for up to 60 minutes. Following the session, participants' ratings of the experience will be measured.
Dark Room
Participants will lay on an air mattress in a dark room with no cell phone and reduced sensory input.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Flotation-REST
Floating in a specialized device (float pod or float cabin) used to attenuate sensory input.
Dark Room
Participants will lay on an air mattress in a dark room with no cell phone and reduced sensory input.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Psychologically healthy
* Adults between the ages of 18-75 years.
Exclusion Criteria
* Diagnosed with neuropathic pain condition or endorsing more than 4 peripheral neuropathy symptoms.
* Diagnosed with any psychiatric condition (e.g., schizophrenia or bipolar disorder).
* Active suicidality with intent or plan.
* Currently taking SSRI medication.
* History of neurological conditions (e.g., epilepsy, stroke, severe traumatic brain injury, Parkinson's disease, Alzheimer's disease or other forms of dementia)
* Any skin conditions or open wounds that could cause pain when exposed to saltwater
* Inability to lay comfortably for 60 minutes
* Pregnant
* Started a new sleep or pain medication within the last 6 weeks
18 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Missouri-Columbia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Steven Pratscher
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Steven Pratscher
Role: PRINCIPAL_INVESTIGATOR
University of Missouri-Columbia
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2017263
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.